TY - JOUR AU - Shibuya, K. AU - Hashimoto, H. AU - Ikegami, N. AU - Nishi, A. AU - Tanimoto, T. AU - Miyata, H. AU - Takemi, K. AU - Reich, M. R. PY - 2011 DA - 2011// TI - Future of Japan’s system of good health at low cost with equity: beyond universal coverage JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)61098-2 DO - 10.1016/S0140-6736(11)61098-2 ID - Shibuya2011 ER - TY - JOUR AU - Hirai, Y. AU - Kinoshita, H. AU - Kusama, M. AU - Yasuda, K. AU - Sugiyama, Y. AU - Ono, S. PY - 2010 DA - 2010// TI - Delays in new drug applications in Japan and industrial R&D strategies JO - Clin Pharmacol Ther VL - 87 UR - https://doi.org/10.1038/clpt.2009.215 DO - 10.1038/clpt.2009.215 ID - Hirai2010 ER - TY - JOUR AU - Tanimoto, T. AU - Murashige, N. AU - Hosoda, M. AU - Kusumi, E. AU - Ono, S. AU - Kami, M. AU - Shibuya, K. PY - 2012 DA - 2012// TI - Vaccination for whom? Time to reinvigorate Japanese vaccine policy JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)61948-5 DO - 10.1016/S0140-6736(12)61948-5 ID - Tanimoto2012 ER - TY - JOUR AU - Luzzato, L. AU - Gianfaldoni, G. AU - Notaro, R. PY - 2011 DA - 2011// TI - Management of paroxysmal nocturnal haemoglobinemia: a personal view JO - Br J Haematol VL - 153 UR - https://doi.org/10.1111/j.1365-2141.2011.08690.x DO - 10.1111/j.1365-2141.2011.08690.x ID - Luzzato2011 ER - TY - STD TI - U.S. Food and Drug Administration: Prescribing information for Soliris.http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125166s172lbl.pdf, UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125166s172lbl.pdf ID - ref5 ER - TY - STD TI - Pharmaceuticals and Medical Devices Agency: Review report of Soliris for paroxysmal nocturnal hemogulobinuria. (in Japanese).http://www.info.pmda.go.jp/shinyaku/P201000032/870056000_22200AMX00316000_A100_1.pdf, UR - http://www.info.pmda.go.jp/shinyaku/P201000032/870056000_22200AMX00316000_A100_1.pdf ID - ref6 ER - TY - STD TI - Pharmaceuticals and Medical Devices Agency: Review report of Soliris for atypical hemolytic uremic syndrome. (in Japanese).http://www.info.pmda.go.jp/shinyaku/P201300125/870056000_22200AMX00316000_A100_1.pdf, UR - http://www.info.pmda.go.jp/shinyaku/P201300125/870056000_22200AMX00316000_A100_1.pdf ID - ref7 ER - TY - JOUR AU - Hillmen, P. AU - Muus, P. AU - Röth, A. AU - Elebute, M. O. AU - Risitano, A. M. AU - Schrezenmeier, H. AU - Szer, J. AU - Browne, P. AU - Maciejewski, J. P. AU - Schubert, J. AU - Urbano-Ispizua, A. AU - de Castro, C. AU - Socié, G. AU - Brodsky, R. A. PY - 2013 DA - 2013// TI - Long-term safety and efficacy of sustained exulizumab treatment in patients with paroxysmal nocturnal haemoglobinuria JO - Br J Haematol VL - 162 UR - https://doi.org/10.1111/bjh.12347 DO - 10.1111/bjh.12347 ID - Hillmen2013 ER - TY - STD TI - European Medicines Agency: Soliris: EPAR – Product Information.http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000791/WC500054208.pdf, UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000791/WC500054208.pdf ID - ref9 ER - TY - STD TI - Pharmaceuticals and Medical Devices Agency: The package insert of Soliris. (in Japanese).http://www.info.pmda.go.jp/downfiles/ph/PDF/870056_6399424A1023_1_03.pdf, UR - http://www.info.pmda.go.jp/downfiles/ph/PDF/870056_6399424A1023_1_03.pdf ID - ref10 ER - TY - STD TI - Centers for Disease Control and Prevention: Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP).http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6202a1.htm, UR - http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6202a1.htm ID - ref11 ER -